STOCK TITAN

Amesite Inc. (AMST) Financials

AMST
FY2026 annual
Revenue $365K +230.2% YoY
Net Income -$3.1M n/m YoY
EPS (Diluted) -$0.63 n/m YoY
Free Cash Flow -$2.2M YoY not available
Market Cap $4.0M as of Oct 23, 2026
Price / Sales 11.1x on $365K revenue, FY2026
Price / Earnings n/m net loss, so no earnings multiple, FY2026
Price / Book 1.5x on $2.7M equity, Q4 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 23, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jun 30, 2026 Reported Currency USD FYE June

Newest figures come from the 10-K for FY2026, filed Sep 23, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMST SEC filings page.

Amesite Inc. (AMST) reported $365K in revenue for fiscal year 2026, up 230.2% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AMST FY2026

Revenue recovered in FY2026, but the business still relies on external financing because operating cash needs remain far larger than sales.

Revenue recovery has not translated into cash self-sufficiency: revenue more than tripled from FY2025 to FY2026, while operating cash outflow fell only 12.6%. That gap indicates the rebound improved reported sales faster than it changed the company’s underlying spending model.

In FY2026, operating cash outflow of $2.1M was nearly six times reported revenue of $365K, so the cost base still overwhelms current sales. R&D was $614K and SG&A was $2.5M, identifying product development and corporate overhead as the main reported spending burden.

Financing cash inflow of $2.3M nearly offset operating cash outflow of $2.1M in FY2026, indicating that much of the cash requirement was funded outside operations. Liabilities were $376K against assets of $3.0M; the current ratio was 6.4x, and the supplied liquidity comparison equaled 12.9 months of reported annual outflow.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

Amesite Inc. does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress
-16.63

Amesite Inc. scores -16.63, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $44.5M against total assets of $3.0M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial
3/7

Amesite Inc. passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 2 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), the one computable operating efficiency signal (asset turnover improving) passes.

Earnings Quality No Cash Backing
N/A

Amesite Inc. reported a net loss of $3.1M while operations used $2.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$79K
YoY+41.9%
QoQ-5.1%
5Y CAGR-21.0%

Amesite Inc. generated $79K in revenue in Q4 2026. This represents an increase of 41.9% from the same quarter a year earlier. Against the prior quarter it is down 5.1%.

EBITDA
-$847K
YoYn/m
QoQn/m

Amesite Inc.'s EBITDA was -$847K in Q4 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$1.0M
YoYn/m
QoQn/m
5Y CAGRn/m

Amesite Inc. reported a net loss of $1.0M in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)
-$0.18
YoYn/m
QoQn/m

Amesite Inc. earned -$0.18 per diluted share (EPS) in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Cash & Balance Sheet

Cash & Debt
$2.3M
YoY-1.5%
QoQ+258.8%
5Y CAGR-26.5%

Amesite Inc. held $2.3M in cash as of Q4 2026; no long-term debt figure is on record for that period.

Shares Outstanding
7M
YoY+43.2%
QoQ+11.9%

Amesite Inc. had 7M shares outstanding in Q4 2026. This represents an increase of 43.2% from the same quarter a year earlier. Against the prior quarter it is up 11.9%.

Free Cash Flow

Not reported for Q4 2026.

Dividends Per Share

Not reported for Q4 2026.

Margins & Returns

Return on Equity
-39.3%
YoY-5.6pp
QoQ+12.8pp
5Y change-23.2pp

Amesite Inc.'s quarterly ROE was -39.3% in Q4 2026: one quarter's net income over shareholder equity, not annualized. This is down 5.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 12.8 percentage points.

Gross Margin

Not reported for Q4 2026.

Operating Margin

Not shown for Q4 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q4 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$212K
YoY+26.3%
QoQ+57.7%

Amesite Inc. invested $212K in research and development in Q4 2026. This represents an increase of 26.3% from the same quarter a year earlier. Against the prior quarter it is up 57.7%.

Share Buybacks

Not reported for Q4 2026.

Capital Expenditures

Not reported for Q4 2026.

AMST Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMST quarterly income statement
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Revenue$79K+41.9%$83K+171.5%$108K+746.8%$94K+738.2%$56K+100.3%$31K-10.4%$13K-69.2%$11K-82.2%
R&D Expenses$212K+26.3%$134K-22.0%$165K-22.2%$103K-26.3%$168K-9.8%$172K-23.1%$212K-36.0%$140K-58.1%
SG&A Expenses$919K+23.2%$633K+15.9%$688K-26.1%$654K-18.2%$746K-29.1%$546K-57.1%$932K+39.8%$799K+17.5%
Operating Income-$1.1Mn/m-$684Kn/m-$745Kn/m-$662Kn/m-$858Kn/m-$688Kn/m-$1.1Mn/m-$927Kn/m
EBITDA-$847Kn/m-$678Kn/m-$739Kn/m-$602Kn/m-$555Kn/m-$681Kn/m-$1.1Mn/m-$809Kn/m
Net Income-$1.0Mn/m-$678Kn/m-$733Kn/m-$642Kn/m-$924Kn/m-$663Kn/m-$1.1Mn/m-$908Kn/m
EPS (Basic)-$0.18n/m-$0.15n/m-$0.16-$0.14-$0.18-$0.16-$0.40n/m-$0.34n/m
EPS (Diluted)-$0.18n/m-$0.15n/m-$0.16-$0.14-$0.18-$0.16-$0.40n/m-$0.34n/m
Diluted Shares (Avg)N/AN/AN/AN/AN/A4MN/AN/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense, Income Tax.

AMST Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMST quarterly balance sheet
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Total Assets$3.0M-2.2%$1.5M-60.8%$2.0M-6.5%$2.6M-18.1%$3.1M-6.5%$3.8M-0.7%$2.1M-53.1%$3.2M-42.5%
Current Assets$2.4M-0.9%$822K-73.8%$1.3M-7.9%$1.9M-21.6%$2.4M-2.8%$3.1M-0.4%$1.4M-62.5%$2.4M-48.6%
Cash & Equivalents$2.3M-1.5%$641K-77.6%$1.2M+124.2%$1.8M+27.6%$2.3M+12.7%$2.9M-3.8%$520K-85.8%$1.4M-69.1%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Accounts Receivable$15K+132.2%$19K+327.4%$7K$10K$6K-78.9%$4KN/AN/A
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$376K+4.8%$190K-9.9%$490K-44.9%$428K-49.3%$359K-55.1%$211K-0.4%$889K+405.1%$843K+220.1%
Current Liabilities$376K+4.8%$190K-9.9%$490K-44.9%$428K-49.3%$359K-55.1%$211K-0.4%$889K+405.1%$843K+220.1%
Non-Current Liabilities$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Equity$2.7M-3.1%$1.3M-63.8%$1.5M+20.9%$2.2M-6.9%$2.7M+8.9%$3.6M-0.7%$1.2M-71.5%$2.3M-55.6%
Retained Earnings-$44.5Mn/m-$43.5Mn/m-$42.8Mn/m-$42.1Mn/m-$41.5Mn/m-$40.5Mn/m-$39.9Mn/m-$38.7Mn/m

Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.

AMST Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMST quarterly cash flow statement
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Operating Cash Flow-$661Kn/m-$449Kn/m-$621Kn/m-$416Kn/m-$439Kn/m-$677Kn/m-$850Kn/m-$488Kn/m
Depreciation & Amortization$78K-74.3%$6K0.0%$6K0.0%$60K-48.9%$303K+153.5%$6K-94.8%$6K-95.5%$118K-22.4%
Stock-Based CompensationN/A$72Kn/m$72K+76.2%$72K+10.4%N/A-$145K$41K$65K+18.8%
Investing Cash Flow-$24Kn/m-$76Kn/m-$44Kn/m-$88Kn/m-$86Kn/m-$80Kn/m-$65Kn/m-$148Kn/m
Financing Cash FlowN/AN/AN/AN/A$0N/AN/AN/A

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

AMST Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AMST quarterly financial ratios
MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-Q
Operating Margin-1329.5%-820.9%-689.7%-702.2%-1538.2%-2240.9%-8862.6%-8243.1%
Net Margin-1318.6%-813.7%-678.0%-681.1%-1657.1%-2161.7%-8790.3%-8071.5%
Return on Equity-39.3%-5.6pp-52.1%-33.6pp-48.6%+41.3pp-29.6%+9.4pp-33.7%+13.2pp-18.4%+20.9pp-89.9%-69.2pp-39.0%-22.0pp
Return on Assets-34.4%-4.6pp-45.4%-28.0pp-36.7%+15.9pp-24.7%+3.9pp-29.8%+5.8pp-17.4%+19.8pp-52.5%-32.6pp-28.6%-12.5pp
Current Ratio6.42-0.4x4.33-10.6x2.72+1.1x4.46+1.6x6.79+3.7x14.880.0x1.63-20.3x2.88-15.1x
Liabilities-to-Equity0.140.0x0.15+0.1x0.32-0.4x0.20-0.2x0.13-0.2x0.060.0x0.71+0.7x0.36+0.3x
Asset Turnover0.030.0x0.060.0x0.050.0x0.040.0x0.020.0x0.010.0x0.010.0x0.000.0x

Not reported in any period shown, so not listed: Gross Margin, Debt-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Amesite Inc. AMST FY2026 $365K -$3.1M N/A $4.0M —
NextPlat Corp NXPL FY2025 $54.3M -$10.5M -19.3% $23.1M 49/100
Lucas GC Limited LGCL FY2025 $149.0M $1.4M 0.9% $2.1M 41/100
CXApp Inc. CXAI FY2025 $4.6M -$13.5M N/A $4.3M 32/100
Smith Micro Software Inc SMSI FY2025 $17.4M -$29.3M N/A $13.0M 39/100
Heartcore Enterprises, Inc. HTCR FY2025 $9.0M $5.8M 64.6% $2.3M 29/100

Frequently Asked Questions

What is Amesite Inc.'s annual revenue?

Amesite Inc. (AMST) reported $365K in total revenue for fiscal year 2026. This represents a 230.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Amesite Inc.'s revenue growing?

Amesite Inc. (AMST) revenue grew by 230.2% year-over-year, from $110K to $365K in fiscal year 2026.

Is Amesite Inc. profitable?

No, Amesite Inc. (AMST) reported a net loss of $3.1M in fiscal year 2026.

Amesite Inc. (AMST) reported diluted earnings per share of -$0.63 for fiscal year 2026. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Amesite Inc. (AMST) had EBITDA of -$2.9M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

Amesite Inc. (AMST) has a return on equity of -116.7% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Amesite Inc. (AMST) recorded an outflow of $2.2M in free cash flow during fiscal year 2026. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Amesite Inc. (AMST) recorded an outflow of $2.1M in operating cash flow during fiscal year 2026, representing cash used by core business activities.

Amesite Inc. (AMST) had $3.0M in total assets as of fiscal year 2026, including both current and long-term assets.

Amesite Inc. (AMST) invested $6K in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Amesite Inc. (AMST) invested $614K in research and development during fiscal year 2026.

Amesite Inc. (AMST) had 7M shares outstanding as of fiscal year 2026.

Amesite Inc. (AMST) had a current ratio of 6.42 as of fiscal year 2026, which is generally considered healthy.

Amesite Inc. (AMST) had a liabilities-to-equity ratio of 0.14 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2026, because the filing data we hold for that year carries no long-term debt figure.

Amesite Inc. (AMST) had a return on assets of -102.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Amesite Inc. (AMST) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2026). The market capitalization is $4.0M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Amesite Inc. (AMST) trades at 11.1x sales, its market capitalization divided by $365K revenue, FY2026. The market capitalization is $4.0M as of Oct 23, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

At the end of fiscal year 2026, Amesite Inc. (AMST) held $2.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $2.1M over that year. Dividing the one by the other, the reported balance equals about 13 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Amesite Inc. (AMST) has an Altman Z-Score of -16.63, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Amesite Inc. (AMST) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Amesite Inc. (AMST) reported a net loss of $3.1M while operations used $2.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Back to top